Azienda Usl Toscana Nord Ovest-Ospedale Civile di Livorno

The medical center is at the forefront of oncology research, focusing on innovative treatments for various cancers. The center's commitment to advancing cancer care is evident through its cutting-edge clinical trials and research initiatives.

• Metastatic Renal Cell Carcinoma (mRCC)
• Immunotherapy
• Targeted Therapy

By exploring novel therapeutic combinations, the center aims to improve patient outcomes and set new standards in cancer treatment.

Specializing in immunotherapy, the center is dedicated to harnessing the body's immune system to fight cancer. This approach is revolutionizing the way cancer is treated, offering hope for more effective and less toxic therapies.

• Nivolumab and ipilimumab Combinations
• Immune Checkpoint Inhibitors
• Personalized Medicine

The center's research in immunotherapy is paving the way for personalized treatment plans that cater to the unique needs of each patient.

With a strong focus on targeted therapy, the center is exploring treatments that specifically target cancer cells while minimizing damage to healthy tissue. This precision medicine approach is transforming cancer care.

• Axitinib Research
• Precision Oncology
• Biomarker Development

Through its targeted therapy research, the center is contributing to the development of more effective and tailored cancer treatments.